期刊
CLINICAL PHARMACOLOGY & THERAPEUTICS
卷 96, 期 5, 页码 609-615出版社
WILEY-BLACKWELL
DOI: 10.1038/clpt.2014.154
关键词
-
资金
- US National Institutes of Health [R01-CA111646, P50CA070907, R01-CA127615, CPRIT RP130502, U19-GM61388, R01-CA138461]
- Center for Translational and Public Health Genomics of the Duncan Family Institute for Cancer Prevention and Risk Assessment, University of Texas MD Anderson Cancer Center
Definitive radiotherapy improves Iocoregional control and survival in inoperable non-small cell lung cancer patients. However, radiation-induced toxicities (pneumonitis/esophagitis) are common dose-limiting inflammatory conditions. We therefore conducted a pathway-based analysis to identify inflammation-related single-nucleotide polymorphisms associated with radiation-induced pneumonitis or esophagitis. A total of 11,930 single-nucleotide polymorphisms were genotyped in 201 stage I-Ill non-small cell lung cancer patients treated with definitive radiotherapy. Validation was performed in an additional 220 non-small cell lung cancer cases. After validation, 19 single-nucleotide polymorphisms remained significant. A polygenic risk score was generated to summarize the effect from validated single-nucleotide polymorphisms. Significant improvements in discriminative ability were observed when the polygenic risk score was added into the clinical/epidemiological variable-based model. We then used 277 lymphoblastoid cell lines to assess radiation sensitivity and expression quantitative trait loci (eQTL) relationships of the identified single-nucleotide polymorphisms. Three genes (PRKCE, DDX58, and TNESF7) were associated with radiation sensitivity. We concluded that inflammation-related genetic variants could contribute to the development of radiation-induced toxicities.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据